Skip to content

Clinical trials

Phase 2 Hepatitis C, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 2 Country / region: United States Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20042
20056
20063
20076
20087
20095
20106
201115
20128
20137
20142
20152
20162
20182
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Terminated3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences11
Hoffmann-La Roche11
Bristol-Myers Squibb5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Vertex Pharmaceuticals Incorporated4
Boehringer Ingelheim3
GlaxoSmithKline3
Merck Sharp & Dohme LLC3
National Institute of Allergy and Infectious Diseases (NIAID)3
AbbVie (prior sponsor, Abbott)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic78
Hepatitis C30
Hepatitis5
Liver Diseases4
Infections3
Virus Diseases3
Fibrosis2
Hepatitis, Chronic2
Acquired Immunodeficiency Syndrome1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.